Local Assessment of Management of Burn Patients (LAMiNAR)

June 26, 2017 updated by: Prof. Dr. Marcus J. Schultz, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Local Assessment of Management of Burn Patients (LAMiNAR) - a Prospective Observational International Multicenter Cohort Study

In the general intensive care unit (ICU) population, there is strong evidence for benefit from lung-protective mechanical ventilation, including the use of low tidal volumes and adequate levels of positive end-expiratory pressure (PEEP). In burn patients it is highly uncertain whether these settings are beneficial and there are even concerns over safety of, in particular use of low tidal volumes. There is lack of international guidelines and consequently ventilation practice in burn patients may widely vary.

The primary objective is to determine ventilation practice in burn ICUs worldwide, focusing on the size of tidal volumes and the levels of PEEP used for burn patients. In addition, data on other strategies considered important in patients who receive ventilation are also collected, including data on neuromuscular blocking agents, sedatives and analgesics, and type and amount of intravenous fluids used in the period of ventilation. The secondary objective is to determine the association between tidal volume size and levels of PEEP, and duration of ventilation in burn patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patient population: Consecutive burn patients admitted to participating burn ICUs who receive invasive ventilation, irrespective of severity of burn injury and/or presence of inhalation trauma are eligible for participation.

Data collection: includes burn patients admitted within a period of three months. Demographic and baseline data are collected from the clinical files on the day of admission. If available, standard of care and clinical outcome parameters are collected daily until day 14, death or discharge from ICU, whatever comes first.

Sample size: The primary objective is to determine (variations in) ventilation practice in burn patients in burn ICUs. Therefore, the sample size is based on the main secondary objective, which is to determine the association between the following ventilator settings: tidal volume, PEEP, FiO2 and mode; and outcome of burn patients. The investigators calculated the sample size for a multiple regression model: a sample size of at least 300 patients is required to have a power of 0.80, a significance level of 0.05, using an estimated effect size of 0.04, while using 4 independent variables in the model.

Ethics Approval: National coordinators will be responsible for clarifying the need for ethics approval and applying for this where appropriate according to local policy. Centres will not be permitted to record data unless ethics approval or an equivalent waiver is in place. The investigators expect that in most, if not every participating country, a patient informed consent is not be required.

Monitoring: Due to the observational nature of the study, a DSMB is not necessary.

Organization: National co-ordinators will lead the project within individual nations and identify participating hospitals, translate study paperwork, distribute study paperwork and ensure necessary regulatory approvals are in place. They provide assistance to the participating clinical sites in trial management, record keeping and data management. Local coordinators in each site will supervise data collection and ensure adherence to Good Clinical Practice during the trial.

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zuid Holland
      • Amsterdam, Zuid Holland, Netherlands, 1105AZ
        • Academic Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Consecutive intubated and ventilated burn patients admitted to participating ICUs during a period of 3 months

Description

Inclusion Criteria:

  • Burns
  • Admission to a participating burn ICU Need for invasive ventilation
  • Informed consent (only if applicable in the country where data are collected)

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilation parameters
Time Frame: Up to 14 days during mechanical ventilation
Tidal volume size; milliliters per kilogram of predicted body weight
Up to 14 days during mechanical ventilation
Ventilation parameters
Time Frame: Up to 14 days during mechanical ventilation
Level of positive end-expiratory pressure (PEEP); cm H2O
Up to 14 days during mechanical ventilation
Ventilation parameters
Time Frame: Up to 14 days during mechanical ventilation
Fraction of oxygen in inspired air (FiO2), %
Up to 14 days during mechanical ventilation
Ventilation parameters
Time Frame: Up to 14 days during mechanical ventilation
Mode of ventilation; assist-control or spontaneous modes of ventilation
Up to 14 days during mechanical ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of Stay in ICU on Day 90
Time Frame: Until day 90
Time between admission and discharge or death
Until day 90
Length of Stay in Hospital on Day 90
Time Frame: Until day 90
Time between admission and discharge or death
Until day 90
All-cause ICU Mortality
Time Frame: Until day 90
Any death during ICU stay
Until day 90
All-cause Hospital Mortality
Time Frame: Until day 90
Any death during hospital stay
Until day 90
Number of ventilator-free days and alive at day 28
Time Frame: From day 1 to day 28
Defined as the number of days, from day 1 to day 28, the patient is alive and breathes without assistance of a mechanical ventilator, if the period of unassisted breathing lasted at least 24 consecutive hours. Notably, if after successful withdrawal of mechanical ventilation the patient requires ventilation for a surgical procedure, this will not count as a 'ventilator day'. If ventilation is prolonged after surgery due to respiratory insufficiency, the day(s) ventilation is required counts as a 'ventilator day'
From day 1 to day 28
Other Ventilation Parameters
Time Frame: Up to 14 days during mechanical ventilation
Peak and plateau pressures or maximum airway pressure
Up to 14 days during mechanical ventilation
Other Ventilation Parameters
Time Frame: Up to 14 days during mechanical ventilation
Respiratory rate
Up to 14 days during mechanical ventilation
Other Ventilation Parameters
Time Frame: Up to 14 days during mechanical ventilation
Inspiration to expiration ratio
Up to 14 days during mechanical ventilation
Other Ventilation Parameters
Time Frame: Up to 14 days during mechanical ventilation
Peripheral oxygen saturation
Up to 14 days during mechanical ventilation
Other Ventilation Parameters
Time Frame: Up to 14 days during mechanical ventilation
Arterial blood gas parameters
Up to 14 days during mechanical ventilation
Need for Tracheostomy
Time Frame: daily up to 14 days from inclusion
Need for tracheostomy, first tracheostomy will be assessed up to 14 days from inclusion
daily up to 14 days from inclusion
Daily Lung Injury Scores
Time Frame: Up to 14 days during mechanical ventilation
Score based on chest X-ray findings (if obtained), PaO2/FiO2, PEEP level and respiratory compliance.
Up to 14 days during mechanical ventilation
Daily Sequential Organ Failure Assessment (SOFA)-scores
Time Frame: Daily up to 14 days from inclusion
six-organ dysfunction/failure score measuring multiple organ failure daily
Daily up to 14 days from inclusion
Complications
Time Frame: Daily up to 14 days from inclusion
Complications will include: Skin and soft tissue infections
Daily up to 14 days from inclusion
Complications
Time Frame: Daily up to 14 days from inclusion
Complications will include: (Ventilator associated) Pneumonia
Daily up to 14 days from inclusion
Complications
Time Frame: Daily up to 14 days from inclusion
Complications will include: Sepsis
Daily up to 14 days from inclusion
Complications
Time Frame: Daily up to 14 days from inclusion
Complications will include: Acute respiratory distress syndrome according to Berlin criteria
Daily up to 14 days from inclusion
Complications
Time Frame: Daily up to 14 days from inclusion
Complications will include: Acute renal failure
Daily up to 14 days from inclusion
Complications
Time Frame: Daily up to 14 days from inclusion
Complications will include: Abdominal compartment syndrome
Daily up to 14 days from inclusion

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Standard care strategies
Time Frame: Daily up to 14 days from inclusion
Strategies considered to be important in patients who receive ventilation, including: Fluid balance, types and dose of fluids used
Daily up to 14 days from inclusion
Standard care strategies
Time Frame: Daily up to 14 days from inclusion
Strategies considered to be important in patients who receive ventilation, including: use of sedative and analgesic drugs
Daily up to 14 days from inclusion
Standard care strategies
Time Frame: Daily up to 14 days from inclusion
Strategies considered to be important in patients who receive ventilation, including: use of sedation and delirium scores
Daily up to 14 days from inclusion
Standard care strategies
Time Frame: Daily up to 14 days from inclusion
Strategies considered to be important in patients who receive ventilation, including: use of neuromuscular blocking agents
Daily up to 14 days from inclusion
Standard care strategies
Time Frame: Daily up to 14 days from inclusion
Strategies considered to be important in patients who receive ventilation, including: use of antibiotic prophylaxis
Daily up to 14 days from inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marcus J. Schultz, MD, PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

May 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

December 4, 2014

First Submitted That Met QC Criteria

December 7, 2014

First Posted (Estimate)

December 9, 2014

Study Record Updates

Last Update Posted (Actual)

June 28, 2017

Last Update Submitted That Met QC Criteria

June 26, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LAMiNAR

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mechanical Ventilation

Clinical Trials on No intervention

3
Subscribe